Introduction: Nosocomial gram-negative bacteremia in critically ill patients is associated with significant morbidity and mortality.
Objectives: In this study we describe the epidemiology, antimicrobial susceptibilities and outcomes of nosocomial gram-negative bacteremia in a large tertiary care general systems intensive care unit over nearly a decade.
Methods:
All patients admitted to the University of Alberta Hospital Intensive Care Unit who developed a hospital-acquired (as per CDC/NHSN definitions) gram-negative bacteremia from January 1, 2004 to December 31, 2012 were identified through prospective Infection Prevention and Control surveillance. Charts were then retrospectively reviewed for patient characteristics, microbial etiology, antimicrobial susceptibilities, treatment and outcomes. Predictors of 30-day mortality were examined using multivariable Cox regression.
Results: Seventy-eight nosocomial gram-negative bacteremias occurred in 74 patients with an infection rate of 0.97/1000 patient days. Patient characteristics included mean age 55 years, 46/74 (62%) male, and 51/74 (69%) medical admission diagnosis. Specific admission diagnoses included 25/74 (34%) respiratory failure, 33/74 (45%) sepsis or septic shock, 7/74 (9%) postliver transplantation and 5/74 (7%) major trauma/burn. Mean APACHE II score was 25 (±8 SD) at the time of ICU admission. Seventy-three (94%) bacteremic events required mechanical ventilation. Mortality was 26/74 (35%) at 30-days and 36/74 (49%) in-hospital. p=0.03), immune suppression (aHR 3.4; p=0.006) and coronary artery disease (aHR 4.5; 95%CI 1.7-11.9; p=0.003) were independently associated with 30-day mortality.
Conclusion:
Nosocomial gram-negative bacteremia is associated with high mortality in critically ill patients. Resistance to ciprofloxacin and piperacillin/tazobactam was common. In addition, carbapenem resistance among pseudomonal isolates was surprisingly high. Despite this, most patients received adequate empiric antimicrobial therapy. Coronary artery disease, immune suppression and adequate empiric antimicrobial therapy were independently associated with 30-day mortality.
